華潤置地(01109.HK)擬2億元購買華潤生命科學產業發展全部股權
格隆匯5月23日丨華潤置地(01109.HK)公告,於2025年5月23日,買方(公司間接全資附屬公司)與賣方及目標公司就買賣目標股權訂立股權轉讓協議,據此,買方同意購買而賣方同意出售目標股權(相當於目標公司華潤生命科學產業發展有限公司全部註冊資本的100%),代價爲人民幣2億元及適用利息。
目標公司爲一間於中國註冊成立的有限公司。於本公告日期,目標公司由賣方擁有100%權益,其主要從事生物科技推廣服務、自然科學及醫療研發、醫療設備銷售、資產管理及物業租賃及管理。
該地塊位於北京大興生物醫藥產業基地的核心地帶,是一個主要產業聚集區。該基地是北京市政府重振現代生物產業的旗艦項目。鑑於其戰略性的工業位置,該地塊上的項目具有成爲行業示範項目的巨大潛力。該項目的開發不僅將加強公司的產業佈局,亦與公司作爲「3+1」城市投資開發運營商的戰略定位完美結合。此次結合彰顯公司致力於推進其戰略目標併爲生物產業的振興作出貢獻的決心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.